Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Elena Araviiskaia, Carlo Pincelli, Adele Sparavigna & Thomas Luger. (2022) The Role of a Novel Generation of Emollients, ‘Emollients Plus’, in Atopic Dermatitis. Clinical, Cosmetic and Investigational Dermatology 15, pages 2705-2719.
Read now
Read now
Ashraf M. Reda, Ayman Elgendi, Ahmed Ismail Ebraheem, Mohammed S. Aldraibi, Mohammed Saleh Qari, Magdy Mohammad R. Abdulghani & Thomas Luger. (2019) A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas. Journal of Dermatological Treatment 30:4, pages 366-373.
Read now
Read now
Sakari Reitamo & Anita Remitz. (2014) An update on current pharmacotherapy options in atopic dermatitis. Expert Opinion on Pharmacotherapy 15:11, pages 1517-1524.
Read now
Read now
Hobart W Walling & Brian L Swick. (2010) Update on the management of chronic eczema: new approaches and emerging treatment options. Clinical, Cosmetic and Investigational Dermatology 3, pages 99-117.
Read now
Read now
Semih Tatlican, Cemile Eren, Damla Atacan, Umut Dalgic, Filiz Canpolat & Fatma Eskioglu. (2010) A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus. Journal of Dermatological Treatment 21:5, pages 322-323.
Read now
Read now
Jonathan M Spergel. (2009) Pimecrolimus cream in the management of patients with atopic eczema. Clinical, Cosmetic and Investigational Dermatology 2, pages 85-93.
Read now
Read now
Chrysovalantis Korfitis, Stamatis Gregoriou, Efstathios Rallis & Dimitris Rigopoulos. (2007) Pimecrolimus versus topical corticosteroids in dermatology. Expert Opinion on Pharmacotherapy 8:10, pages 1565-1573.
Read now
Read now
Alan B. Fleischer$suffix/text()$suffix/text(), William Abramovits, Debra Breneman & Eileen Jaracz. (2007) Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. Journal of Dermatological Treatment 18:3, pages 151-157.
Read now
Read now
Uwe Wollina, Gesina Hansel, André Koch & Mohamed Badawy Abdel-Naser. (2006) Topical pimecrolimus for skin disease other than atopic dermatitis. Expert Opinion on Pharmacotherapy 7:14, pages 1967-1975.
Read now
Read now
Joseph F Fowler. (2006) Pimecrolimus, a topical calcineurin inhibitor for atopic dermatitis and other inflammatory skin diseases. Expert Review of Dermatology 1:3, pages 343-354.
Read now
Read now
Articles from other publishers (64)
Derek K. Chu, Alexandro W.L. Chu, Daniel G. Rayner, Gordon H. Guyatt, Juan José Yepes-Nuñez, Luis Gomez-Escobar, Lucia C. Pérez-Herrera, Juan Pablo Díaz Martinez, Romina Brignardello-Petersen, Behnam Sadeghirad, Melanie M. Wong, Renata Ceccacci, Irene X. Zhao, John Basmaji, Margaret MacDonald, Xiajing Chu, Nazmul Islam, Ya Gao, Ariel Izcovich, Rachel N. Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Korey Capozza, Lina Chen, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Jennifer LeBovidge, Peter A. Lio, Stephen A. Martin, Monica O’Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Wendy Smith Begolka, Julie Wang, Kathryn E. Wheeler, Donna D. Gardner & Lynda Schneider. (2023) Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. Journal of Allergy and Clinical Immunology 152:6, pages 1493-1519.
Crossref
Crossref
Astrid Herzum, Corrado Occella, Lodovica Gariazzo, Carlotta Pastorino & Gianmaria Viglizzo. (2023) Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores. Journal of Clinical Medicine 12:21, pages 6813.
Crossref
Crossref
Robert Sidbury, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu & Dawn M.R. Davis. (2023) Guidelines of care for the management of atopic dermatitis in adults with topical therapies. Journal of the American Academy of Dermatology 89:1, pages e1-e20.
Crossref
Crossref
Jose W. Ricardo, Marianne Gosch, Yu Wang, Drew N. Wright & Joseph Jorizzo. (2023) Evaluating the risk of skin atrophy induced by short-term topical corticosteroid use in atopic dermatitis lesional skin: A systematic review. JAAD International.
Crossref
Crossref
Joseph Pena, Priscila Arellano Zameza, Jessica N. Pixley, Anita Remitz & Steven R. Feldman. (2023) A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis. The Journal of Allergy and Clinical Immunology: In Practice 11:5, pages 1347-1359.
Crossref
Crossref
Paula Finnegan, Michelle Murphy & Cathal O’Connor. (2023) #corticophobia: a review on online misinformation related to topical steroids. Clinical and Experimental Dermatology 48:2, pages 112-115.
Crossref
Crossref
Niveditha Devasenapathy, Alexandro Chu, Melanie Wong, Archita Srivastava, Renata Ceccacci, Clement Lin, Margaret MacDonald, Aaron Wen, Jeremy Steen, Mitchell Levine, Lonnie Pyne, Lynda Schneider, Derek K Chu, Rachel Netahe Asiniwasis, Mark Boguniewicz, Renata Ceccacci, Lina Chen, Alexandro Chu, Derek K Chu, Anna De Benedetto, Niveditha Devasenapathy, Winfred T Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mitchell Levine, Clement Lin, Mary Laura Lind, Peter A Lio, Margaret MacDonald, Stephen A Martin, Monica O'Brien, Peck Y Ong, Lonnie Pyne, Lynda Schneider, Jonathan I Silverberg, Jonathan M Spergel, Archita Srivastava, Jeremy Steen, Julie Wang, Aaron Wen & Melanie Wong. (2023) Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. The Lancet Child & Adolescent Health 7:1, pages 13-25.
Crossref
Crossref
Yik-Ling Chew, Mei-Ann Khor, Zhao Xu, Sue-Kei Lee, Jing-Wen Keng, Sze-Huey Sang, Gabriel Akyirem Akowuah, Khang Wen Goh, Kai Bin Liew & Long Chiau Ming. (2022) Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: Food Ingredients as Complementary and Alternative Therapies for Atopic Dermatitis-A Comprehensive Review. Molecules 27:17, pages 5475.
Crossref
Crossref
Zuotao Zhao, Xing-Hua Gao, Wei Li, Hua Wang, Yunsheng Liang, Jianping Tang, Xu Yao, Hua Zhao & Thomas Luger. (2022) Experts’ Consensus on the Use of Pimecrolimus in Atopic Dermatitis in China: A TCS-Sparing Practical Approach. Dermatology and Therapy 12:4, pages 933-947.
Crossref
Crossref
Emma Axon, Joanne R Chalmers, Miriam Santer, Matthew J Ridd, Sandra Lawton, Sinead M Langan, Douglas J C Grindlay, Ingrid Muller, Amanda Roberts, Amina Ahmed, Hywel C Williams & Kim S Thomas. (2021) Safety of topical corticosteroids in atopic eczema: an umbrella review. BMJ Open 11:7, pages e046476.
Crossref
Crossref
T. Luger, A.S. Paller, A.D. Irvine, R. Sidbury, L.F. Eichenfield, T. Werfel & T. Bieber. (2021) Topical therapy of atopic dermatitis with a focus on pimecrolimus. Journal of the European Academy of Dermatology and Venereology 35:7, pages 1505-1518.
Crossref
Crossref
Thomas Luger, Masayuki Amagai, Brigitte Dreno, Marie-Ange Dagnelie, Wilson Liao, Kenji Kabashima, Tamara Schikowski, Ehrhardt Proksch, Peter M. Elias, Michel Simon, Eric Simpson, Erin Grinich & Matthias Schmuth. (2021) Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. Journal of Dermatological Science 102:3, pages 142-157.
Crossref
Crossref
Charles Camisa & Craig Garofola. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
511
527.e6
.
Т. Люгер, Л. Раеве, К. Гельметти, Т. Какуру, А. Катсару, Д. Ламберт, М. Моррен, А. Оранье, М. Рюэр, С. Сердароглу, А. Торрело & Т. Верфель. (2020) Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs. Педиатрия. Восточная Европа:1, pages 74-91.
Crossref
Crossref
Steven Madsen, Kyla N. Price, Vivian Y. Shi & Peter A. Lio. (2020) Pearls in Mitigating Application Pain of Topical Nonsteroidal Agents. Dermatology 236:5, pages 477-480.
Crossref
Crossref
Nikolay N. Murashkin, Roman V. Epishev, Dmitri V. Fedorov, Alexander I. Materikin, Eduard T. Ambarchyan, Leonid A. Opryatin, Alena A. Savelova, Roman A. Ivanov & Wasel Ahmad. (2019) Sensitive Skin Syndrome in Children with Atopic Dermatitis: Pathogenesis and Management Features. Current Pediatrics 18:4, pages 285-293.
Crossref
Crossref
Chih-ho Hong, Melinda Gooderham & Robert Bissonnette. (2019) Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery 23:4_suppl, pages 5S-10S.
Crossref
Crossref
Zoe D. Draelos, Steven R. Feldman, Brian Berman, Melissa Olivadoti, Debra Sierka, Anna M. Tallman, Michael A. Zielinski, William C. Ports & Sheryl Baldwin. (2019) Tolerability of Topical Treatments for Atopic Dermatitis. Dermatology and Therapy 9:1, pages 71-102.
Crossref
Crossref
Yik-Ling Chew, Mayasah Al-Nema & Vivian Wai-Mun Ong. (2018) Management and treatment of atopic dermatitis with modern therapies, complementary and alternative medicines: a review. Oriental Pharmacy and Experimental Medicine 18:2, pages 67-76.
Crossref
Crossref
James C. Prezzano & Lisa A. Beck. (2017) Long-Term Treatment of Atopic Dermatitis. Dermatologic Clinics 35:3, pages 335-349.
Crossref
Crossref
C.-C. Chi, G. Kirtschig, W. Aberer, J.-P. Gabbud, J. Lipozenčić, S. Kárpáti, U.-F. Haustein, F. Wojnarowska & T. Zuberbier. (2017) Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy. Journal of the European Academy of Dermatology and Venereology 31:5, pages 761-773.
Crossref
Crossref
Thomas A. Luger, Ian McDonald & Martin Steinhoff. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
791
802
.
Van Nguyen, Lauren Simon & Ecler Jaqua. (2016) Allergic Dermatoses. Primary Care: Clinics in Office Practice 43:3, pages 433-449.
Crossref
Crossref
Joris A. Broeders, Usama Ahmed Ali & Gayle Fischer. (2016) Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience. Journal of the American Academy of Dermatology 75:2, pages 410-419.e3.
Crossref
Crossref
Helen Nankervis, Kim S Thomas, Finola M Delamere, Sébastien Barbarot, Natasha K Rogers & Hywel C Williams. (2016) Scoping systematic review of treatments for eczema. Programme Grants for Applied Research 4:7, pages 1-480.
Crossref
Crossref
Werfel Thomas, Aberer Werner, Ahrens FrankAugustin Matthias, Biedermann Tilo, Diepgen Thomas, Fölster-Holst Regina, Gieler Uwe, Heratizadeh Annice, Kahle JuliaKapp Alexander, Nast AlexanderNemat KatjaOtt HagenPrzybilla Bernhard, Roecken Martin, Schlaeger MartinSchmid-Grendelmeier Peter, Schmitt JochenSchwennesen ThomasStaab DorisWorm Margitta. (2016) Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis]. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 14:1, pages e1-e75.
Crossref
Crossref
Mark Boguniewicz & Donald Y.M. Leung. 2016. Pediatric Allergy: Principles and Practice. Pediatric Allergy: Principles and Practice
448
457.e2
.
D. V. Zaslavsky. (2015) Пимекролимус в лечении атопического дерматита у детей. Вопросы безопасности и эффективности. Опыт пятилетнего применения. Vestnik dermatologii i venerologii 91:4, pages 119-125.
Crossref
Crossref
Brian Keng Yong Chia & Hong Liang Tey. (2015) Systematic Review on the Efficacy, Safety, and Cost-Effectiveness of Topical Calcineurin Inhibitors in Atopic Dermatitis. Dermatitis 26:3, pages 122-132.
Crossref
Crossref
Bardur SigurgeirssonAndrzej BoznanskiGail ToddAndré VertruyenMarie-Louise A. SchuttelaarXuejun ZhuUwe SchauerPaul QaqundahYves PoulinSigurdur KristjanssonAndrea von BergAntonio NietoMark BoguniewiczAmy S. PallerRada DakovicJohannes Ring & Thomas Luger. (2015) Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial. Pediatrics 135:4, pages 597-606.
Crossref
Crossref
Thomas Werfel, Nicolaus Schwerk, Gesine Hansen & Alexander Kapp. (2014) The Diagnosis and Graded Therapy of Atopic Dermatitis. Deutsches Ärzteblatt international.
Crossref
Crossref
Chunyun Huang & Youyu Sheng. (2014) Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis. PLoS ONE 9:4, pages e93095.
Crossref
Crossref
Thomas BieberSakari ReitamoAnita Remitz. 2013. Advances in the Management of Atopic Dermatitis. Advances in the Management of Atopic Dermatitis
62
72
.
Michael R. Warner & Charles Camisa. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
487
504.e5
.
Hillary C. Frankel & Abrar A. Qureshi. (2012) Comparative Effectiveness of Topical Calcineurin Inhibitors in Adult Patients with Atopic Dermatitis. American Journal of Clinical Dermatology 13:2, pages 113-123.
Crossref
Crossref
Alicja Grzanka, Jadwiga Zebracka‐Gala, Regina Rachowska, Andrzej Bozek, Małgorzata Kowalska & Jerzy Jarzab. (2011) The effect of pimecrolimus on expression of genes associated with skin barrier dysfunction in atopic dermatitis skin lesions. Experimental Dermatology 21:3, pages 184-188.
Crossref
Crossref
C.-C. Chi, G. Kirtschig, W. Aberer, J.-P. Gabbud, J. Lipozenčić, S. Kárpáti, U.-F. Haustein, T. Zuberbier & F. Wojnarowska. (2011) Evidence-based (S3) guideline on topical corticosteroids in pregnancy. British Journal of Dermatology 165:5, pages 943-952.
Crossref
Crossref
Kathryn J. Martires, Diana S. Domingo, Andrew Hsia, Pingfu Fu, Kevin D. Cooper & Elma D. Baron. (2011) Effects of pimecrolimus versus triamcinolone on Langerhans cells after UV exposure. Experimental Dermatology 20:3, pages 280-282.
Crossref
Crossref
Sakari Reitamo, Johanna M Mandelin & Anita Remitz. (2011) Long-term management of atopic dermatitis: evidence from recent clinical trials. Clinical Investigation 1:1, pages 171-177.
Crossref
Crossref
P. S. Friedmann, M. R. Ardern‐Jones & C. A. Holden. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology
1
34
.
Mark Boguniewicz & Donald Y.M. Leung. 2010. Pediatric Allergy: Principles and Practice. Pediatric Allergy: Principles and Practice
564
574
.
Thomas Werfel. (2009) Topical use of pimecrolimus in atopic dermatitis: Update on the safety and efficacy. Journal der Deutschen Dermatologischen Gesellschaft 7:9, pages 739-742.
Crossref
Crossref
Mireille Ruer-Mulard, Werner Aberer, Anthony Gunstone, Outi-Maria Kekki, Jose Luis López Estebaranz, André Vertruyen, Achim Guettner & Thomas Hultsch. (2009) Twice-daily versus Once-daily Applications of Pimecrolimus Cream 1% for the Prevention of Disease Relapse in Pediatric Patients with Atopic Dermatitis. Pediatric Dermatology 26:5, pages 551-558.
Crossref
Crossref
Seong Soo Joo, Sung Geun Kim, Sun Eun Choi, Yun-Bae Kim, Hee Yong Park, Seong Jun Seo, Young Wook Choi, Min Won Lee & Do Ik Lee. (2009) Suppression of T cell activation by hirsutenone, isolated from the bark of Alnus japonica, and its therapeutic advantages for atopic dermatitis. European Journal of Pharmacology 614:1-3, pages 98-105.
Crossref
Crossref
Mohammad Maged. Y. El-Batawy, Manal A.-W. Bosseila, Heba M. Mashaly & Vanessa Suzan G.A. Hafez. (2009) Topical calcineurin inhibitors in atopic dermatitis: A systematic review and meta-analysis. Journal of Dermatological Science 54:2, pages 76-87.
Crossref
Crossref
B Sigurgeirsson, V Ho, C Ferrándiz, K Andriano, A Grinienko & P Jimenez. (2008) Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis. Journal of the European Academy of Dermatology and Venereology 22:11, pages 1290-1301.
Crossref
Crossref
H. Gollnick, R. Kaufmann, D. Stough, H. Heikkila, K. Andriano, A. Grinienko & P. Jimenez. (2008) Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. British Journal of Dermatology 158:5, pages 1083-1093.
Crossref
Crossref
A. Bewley. (2008) Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. British Journal of Dermatology 158:5, pages 917-920.
Crossref
Crossref
ROBERT SIDBURY. 2008. Managing the Allergic Patient. Managing the Allergic Patient
319
334
.
Thomas A. Luger & Martin Steinhoff. 2008. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
539
549
.
Darren M Ashcroft, Li-Chia Chen, Ruth Garside, Ken Stein & Hywel C Williams. (2007) Topical pimecrolimus for eczema. Cochrane Database of Systematic Reviews 2010:1.
Crossref
Crossref
Tae Young Yoon, Hee Jung Kim & Mi Kyeong Kim. (2007) Pimecrolimus-induced rosacea-like demodicidosis. International Journal of Dermatology 46:10, pages 1103-1105.
Crossref
Crossref
J. Callen, S. Chamlin, L.F. Eichenfield, C. Ellis, M. Girardi, M. Goldfarb, J. Hanifin, P. Lee, D. Margolis, A.S. Paller, D. Piacquadio, W. Peterson, K. Kaulback, M. Fennerty & B.U. Wintroub. (2007) A systematic review of the safety of topical therapies for atopic dermatitis. British Journal of Dermatology 156:2, pages 203-221.
Crossref
Crossref
Felix Braun & Matthias Behrend. 2007.
424
479
.
Carlo Pelfini. 2007. La scuola dell’atopia. La scuola dell’atopia
249
274
.
Jann L??bbe, Sheila F Friedlander, Bernard Cribier, Marie-Anne Morren, Amaro Garc??a-D??ez, Carlo Gelmetti, Heidelore Hofmann, Ronald H Houwing, Stephen Kownacki, Richard G B Langley, Marie Virtanen, Klaus Wolff, Steve Wisseh, Claire McGeown, Beatrice Abrams & Dirk Schneider. (2006) Safety, Efficacy, and Dosage of 1% Pimecrolimus Cream for the Treatment of Atopic Dermatitis in Daily Practice. American Journal of Clinical Dermatology 7:2, pages 121-131.
Crossref
Crossref
S. Reitamo & A. Remitz. 2006. Handbook of Atopic Eczema. Handbook of Atopic Eczema
570
575
.
J Ring, J Barker, H Behrendt, L Braathen, U Darsow, L Dubertret, A Giannetti, J Hawk, H Honigsmann, L Kemeny, T Luger, M Meurer, G Murphy, A Peserico, A Ranki, T Reunala, J Saurat, W Sterry & P Kerkhof. (2005) Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors. Position statement of the European Dermatology Forum. Journal of the European Academy of Dermatology and Venereology 19:6, pages 663-671.
Crossref
Crossref
Daniel B. Yarosh, Arely V. Pena, Stephanie L. Nay, Matthew T. Canning & David A. Brown. (2005) Calcineurin Inhibitors Decrease DNA Repair and Apoptosis in Human Keratinocytes Following Ultraviolet B Irradiation. Journal of Investigative Dermatology 125:5, pages 1020-1025.
Crossref
Crossref
Paolo Gisondi, Charles N. Ellis & Giampiero Girolomoni. (2005) Pimecrolimus in dermatology: atopic dermatitis and beyond. International Journal of Clinical Practice 59:8, pages 969-974.
Crossref
Crossref
Hans Christian Korting. (2005) Erhaltungsbehandlung und Fruhintervention - Das neue Paradigma beim Management des atopischen Ekzems. Maintenance treatment and early intervention - The new paradigm in the management of atopic eczema. Journal der Deutschen Dermatologischen Gesellschaft 3:7, pages 519-523.
Crossref
Crossref
William Abramovits. (2005) A clinician's paradigm in the treatment of atopic dermatitis. Journal of the American Academy of Dermatology 53:1, pages S70-S77.
Crossref
Crossref
Hywel C. Williams. (2005) Atopic Dermatitis. New England Journal of Medicine 352:22, pages 2314-2324.
Crossref
Crossref
Kristine Breuer, Thomas T Werfel & Alexander Kapp. (2005) Pimecrolimus for the treatment of atopic dermatitis. Therapy 2:1, pages 37-56.
Crossref
Crossref